How to build flexibility into your CGT manufacturing process while maintaining regulatory compliance
MasterControl research shows 40% of advanced therapy executives aren't confident they can meet CGT demand over the next three ...
More than two-thirds – 67% - of first responders organisations have deployed new cybersecurity protections in the last 12 ...
The US FDA has expanded the approval of Regeneron Pharmaceuticals' fully human monoclonal antibody, Evkeeza (evinacumab-dgnb) ...
Amgen has revealed a significant investment plan, earmarking $650m to enhance its manufacturing operations in the US.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback